Leflunomide, a potential immunosuppressant for pancreatic islet transplantation.
Guo
Z
Z
Department of General Surgery, Rush-Presbyterian-St Luke's Medical Center, Chicago, Illinois 60612, USA.
Chong
A S
AS
Shen
J
J
Foster
P
P
Sankary
H N
HN
McChesney
L
L
Mital
D
D
Jensik
S C
SC
Gebel
H
H
Williams
J W
JW
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use / Q000633:toxicity; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000601:surgery*; D005951:Glucose Tolerance Test; D007166:Immunosuppressive Agents / Q000627:therapeutic use* / Q000633:toxicity; D016381:Islets of Langerhans Transplantation / Q000276:immunology* / Q000502:physiology; D007555:Isoxazoles / Q000627:therapeutic use* / Q000633:toxicity; D000077339:Leflunomide; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000627:therapeutic use / Q000633:toxicity; D016042:Transplantation, Heterotopic; D014185:Transplantation, Isogeneic
D001786:Blood Glucose; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D016572:Cyclosporine; D000077339:Leflunomide; D016559:Tacrolimus